A multiclinic double-blind trial of the anxiolytic properties of lorazepam in psychiatric outpatient practice
Lipman, R.; Vanov, S.K.; Richards, D.J.
Psychopharmacology Bulletin 13(2): 17-19
1977
ISSN/ISBN: 0048-5764 PMID: 16308 Document Number: 112964
Document emailed within 1 workday
Related Documents
Lasich, A.J. 1974: Evaluation of lorazepam as an anxiolytic agent in psychiatric practice South African Medical Journal 48(16): 681-6831982: Low doses v standard dose of reserpine. A randomized, double-blind, multiclinic trial in patients taking chlorthalidone JAMA 248(19): 2471-2477
Diamond, R.J. 1983: Outpatient use of a double-blind medication trial: a clinical example Journal of Clinical Psychiatry 44(8): 304-305
Ueda, Y.; Tojo, S.; Hatano, M.; Furukawa, T.; Yoshinaga, K.; Kinoshita, Y.; Takeuchi, J.; Kato, E.; Ohno, J.; Kobayashi, K.; Abe, H.; Omae, S. 1979: Clinical effects of dipyridamole (Persantin) on nephrotic syndrome--multiclinic double blind test Nihon Jinzo Gakkai Shi 21(11): 1171-1183
Neville, R.G.; Crombie, I.K.; McDevitt, D.G. 1991: A double-blind placebo-controlled trial of theophylline in general practice British Journal of Clinical Practice 45(1): 14-17
Hart, W.L.; Parmley, L.F. 1978: The effect of lorazepam on hypertension-associated anxiety: a double-blind study Journal of Clinical Psychiatry 39(10 Part 2): 41-45
Ruiz, A.T. 1983: A double-blind study of alprazolam and lorazepam in the treatment of anxiety Journal of Clinical Psychiatry 44(2): 60-62
Cohn, J.B. 1984: Double-blind crossover comparison of triazolam and lorazepam in the posthypnotic state Journal of Clinical Psychiatry 45(3): 104-107
Lennox, I.G.; Asbury, J.F.; Couldrick, W.G.; Beswick, K.B. 1978: Viloxazine and amitriptyline in depressive illness. a double blind controlled trial in general practice Practitioner 220(1315): 153-156
Montgomery, B.A.; Cullinan, T.R.; Bayley, A.J. 1970: A double-blind comparative trial of doxepin hydrochloride and chlordiazepoxide in anxiety and depression in general practice British Journal of Clinical Practice 24(5): 207-209
Pérez Machado, L.; Hinestrosa, H.; Dejman, E.; Marín, L.; García Machado, R.; Ortega Borjas, J.A. 1979: Double-blind evaluation of a benzodiazepine compound (lorazepam) as premedication in upper digestive endoscopy G.E.N 33(1): 15-23
Miller, W.C.; McCurdy, L. 1984: A double-blind comparison of the efficacy and safety of lorazepam and diazepam in the treatment of the acute alcohol withdrawal syndrome Clinical Therapeutics 6(3): 364-371
Rosenberg, I.U.; Ostensen, A.I.; Fonnelo, H. 1976: Double-blind multicenter trial in general practice on fluphenthixol versus nortriptyline in patients with anxiety-depression-asthenia (the "ADA"-syndrome) Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 96(4): 229-233; 255
Ho, E.T.; Trookman, N.S.; Sperber, B.R.; Rizer, R.L.; Spindler, R.; Sonti, S.; Gotz, V.; Mehta, R. 2012: A randomized, double-blind, controlled comparative trial of the anti-aging properties of non-prescription tri-retinol 1.1% vs. prescription tretinoin 0.025% Journal of Drugs in Dermatology: Jdd 11(1): 64-69
Clerico, M.; Bertetto, O.; Morandini, M.P.; Cardinali, C.; Giaccone, G. 1993: Antiemetic activity of oral lorazepam in addition to methylprednisolone and metoclopramide in the prophylactic treatment of vomiting induced by cisplatin. A double-blind, placebo-controlled study with crossover design Tumori 79(2): 119-122
Spear, S.L.; Matsuba, H.; Romm, S.; Little, J.W. 1991: Methyl prednisolone in double-lumen gel-saline submuscular mammary prostheses: a double-blind, prospective, controlled clinical trial Plastic and Reconstructive Surgery 87(3): 483-487; Discussion: 488-489
Mantero, J.C.; Kishore, N.; Ziemek, J.; Stifano, G.; Zammitti, C.; Khanna, D.; Gordon, J.K.; Spiera, R.; Zhang, Y.; Simms, R.W.; Lafyatis, R. 2018: Randomised, double-blind, placebo-controlled trial of IL1-trap, rilonacept, in systemic sclerosis. a phase I/Ii biomarker trial Clinical and Experimental Rheumatology 36 Suppl 113(4): 146-149
De Buck, R.; Boon, H.; Pelc, I. 1972: Comparative study of the anxiolytic efficacy of lorazepam (WY 4036) and diazepam (Valium) Acta Psychiatrica Belgica 72(2): 185-198
Bieber, T.; Chosidow, O.; Bodsworth, N.; Tyring, S.; Hercogova, J.; Bloch, M.; Davis, M.; Lewis, M.; Boutolleau, D.; Attali, P.; Bisshop, F.R.; Bloch, M.T.; Bodworth, N.J.; Aster, V.; Asterova, J.; Hercogova, J.; Klimesova, R.; Krajsova, I.; Ben Slama, L.; Cambazard, F.; Chosidow, O.; Dubertret, L.; Granel, F.; Humbert, P.; Ortonne, J.P.; Rostain, G.; Ruer-Mulard, M.; Vaillant, L.; Beiber, T.; Degen, A.J.; Dörzapf, O.; von Hake, G.; Miller, A.; Naudts, I.; Steinert, M.; Stockfleth, E.; Weihe, J.; Wunderlich, U.; Jasieniak-Pinis, G.; Kazina, M.; Pawlaczyk-Strugala, E.; Placek, W.; Petryka, R.; Romanowski, L.; Dixon, C.J.; Lewis, M.; Sharma, R.; Archuleta, M.; Baker, D.A.; Cady, R.K.; Conant, M.A.; Crump, W.L.; Davis, M.G.; Dunlap, F.E.; Lee 2014: Efficacy and safety of aciclovir mucoadhesive buccal tablet in immunocompetent patients with labial herpes (LIP Trial): a double-blind, placebo-controlled, self-initiated trial Journal of Drugs in Dermatology: Jdd 13(7): 791-798
Villeneuve, A.; Bourassa, G.; Golmann, M.; Lachance, R. 1972: Comparative determination by the double blind method of capuride, secobarbital and placebos in psychiatric patients Therapie 27(5): 821-830